Semen Analysis on TRT: What to Expect for Fertility
Understand how Testosterone Replacement Therapy (TRT) impacts male fertility and what a semen analysis reveals. Learn to interpret results and explore options
Last Updated: JULY 2024
Male factor infertility contributes to 30-50% of all infertility cases, affecting approximately 7% of men globally (Sharlip et al., 2021, Fertility and Sterility). For men seeking to optimize their health and vitality through Testosterone Replacement Therapy (TRT), understanding its impact on fertility is paramount. While TRT can profoundly improve symptoms of low testosterone—such as fatigue, low libido, and mood disturbances—it fundamentally alters the body’s natural reproductive processes. This guide details what to expect from semen analysis while on TRT and explores effective strategies to preserve or restore fertility. The common lower bound for diagnosing low testosterone, 264 ng/dL, was established using data from the 1970s that included elderly and sick men, not a population optimized for peak health and reproductive function.
The Mechanism: TRT and the HPTA Axis
Testosterone Replacement Therapy works by providing exogenous testosterone, effectively bypassing the body’s natural production loop. This has a direct consequence for fertility. The brain’s hypothalamus-pituitary-testicular axis (HPTA) regulates endogenous testosterone and sperm production. When the brain detects adequate testosterone levels (from exogenous TRT), it signals the pituitary gland to reduce the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).
LH is crucial for stimulating Leydig cells in the testes to produce testosterone. FSH is essential for stimulating Sertoli cells, which support spermatogenesis (sperm production). With suppressed LH and FSH, the testes receive reduced signals to produce their own testosterone and, critically, to produce sperm. This leads to a decline in intratesticular testosterone (ITT) levels, which are hundreds of times higher than circulating testosterone and absolutely necessary for robust sperm production. The result is often testicular atrophy (shrinkage) and a significant reduction in sperm count, or even complete absence of sperm (azoospermia).
Understanding Semen Analysis Parameters
A semen analysis is the cornerstone of male fertility evaluation. It assesses various parameters of the ejaculated semen to determine sperm quality and quantity.
Key Semen Parameters (WHO 6th Edition, 2021 Reference Values):
- Semen Volume: The amount of fluid ejaculated. Normal: ≥ 1.4 mL.
- Sperm Concentration: The number of sperm per milliliter of semen. Normal: ≥ 16 million sperm/mL.
- Total Sperm Count: The total number of sperm in the entire ejaculate. Normal: ≥ 39 million sperm.
- Total Motility: The percentage of sperm that are moving. Normal: ≥ 42%.
- Progressive Motility: The percentage of sperm moving actively and progressively (forward). Normal: ≥ 30%.
- Normal Morphology: The percentage of sperm with normal shape and structure. Normal: ≥ 4%.
Typical Changes in Semen Parameters on TRT
For men on testosterone monotherapy (e.g., 100–200mg testosterone cypionate or enanthate per week), semen analysis will almost universally show a dramatic decline in sperm parameters. This suppression can occur within weeks to months of starting TRT.
Expected Semen Analysis Findings on TRT Monotherapy:
| Parameter | Before TRT (Normal Range) | On TRT Monotherapy | Implications |
|---|---|---|---|
| Sperm Concentration | ≥ 16 million/mL | Often < 5 million/mL, or 0 | Oligozoospermia (low count) or Azoospermia (none) |
| Total Sperm Count | ≥ 39 million | Often < 10 million, or 0 | Severe impact on fertility |
| Total Motility | ≥ 42% | Reduced | Fewer viable sperm |
| Progressive Motility | ≥ 30% | Reduced | Decreased chance of natural conception |
| Normal Morphology | ≥ 4% | Potentially Reduced | May indicate overall testicular dysfunction |
| Testicular Size | Normal | Often Atrophied | Due to suppressed endogenous testosterone |
Studies have consistently demonstrated this effect. For example, a significant study by Wang et al. (2000) in the Journal of Clinical Endocrinology & Metabolism showed that weekly testosterone enanthate injections (200 mg) led to azoospermia (no sperm) in approximately 65% of men, and severe oligozoospermia (< 3 million sperm/mL) in an additional 20%. This highlights the potent contraceptive effect of exogenous testosterone.
Strategies to Preserve or Restore Fertility on TRT
Fortunately, desiring fertility does not necessarily mean foregoing TRT. Several strategies can mitigate the suppressive effects of TRT on sperm production. As the American Urological Association (AUA) Guideline states, “Testosterone replacement therapy (TRT) is generally contraindicated in men desiring fertility unless co-administered with a fertility-sparing agent such as human chorionic gonadotropin (hCG
Sources & Citations
Get TRT Updates
Evidence-based insights on testosterone therapy delivered weekly. No spam, unsubscribe anytime.